Literature DB >> 17174804

The Achilles heel of SPECT imaging: the false-positive scans--or are they?

Ami E Iskandrian.   

Abstract

Mesh：

Year:  2006        PMID： 17174804     DOI： 10.1016/j.nuclcard.2006.09.005

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  13 in total

Review 1.  Coronary physiology revisited : practical insights from the cardiac catheterization laboratory.

Authors:  M J Kern
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

2.  Value of peripheral vascular endothelial function in the detection of relative myocardial ischemia in asymptomatic type 2 diabetic patients who underwent myocardial perfusion imaging.

Authors:  Georgios I Papaioannou; Christos Kasapis; Richard L Seip; Neil J Grey; Deborah Katten; Frans J Th Wackers; Silvio E Inzucchi; Samuel Engel; Amy Taylor; Lawrence H Young; Deborah A Chyun; Janice A Davey; Ami E Iskandrian; Robert E Ratner; Evelyn C Robinson; Stella Carolan; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

3.  Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.

Authors:  J W Doucette; P D Corl; H M Payne; A E Flynn; M Goto; M Nassi; J Segal
Journal:  Circulation       Date:  1992-05       Impact factor: 29.690

Review 4.  Sexual dysfunction and cardiovascular disease: integrative concepts and strategies.

Authors:  Kevin L Billups
Journal:  Am J Cardiol       Date:  2005-11-15       Impact factor: 2.778

5.  Relation between effects of adenosine on brachial artery reactivity and perfusion pattern in patients with known or suspected coronary artery disease.

Authors:  Deval Mehta; Gurpreet Baweja; Rajesh Venkataraman; Gilbert J Zoghbi; Thein Htay; Jaekyeong Heo; Navin C Nanda; Ami E Iskandrian
Journal:  Am J Cardiol       Date:  2005-01-15       Impact factor: 2.778

6.  Vascular endothelial dysfunction is associated with reversible myocardial perfusion defects in the absence of obstructive coronary artery disease.

Authors:  Prem Soman; Devang M Dave; James E Udelson; Hui Han; Husam Z Ouda; Ayan R Patel; Richard H Karas; Jeffrey T Kuvin
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 7.  Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.

Authors:  A S Iskandrian; M S Verani; J Heo
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

8.  Intracoronary pressure and flow velocity with sensor-tip guidewires: a new methodologic approach for assessment of coronary hemodynamics before and after coronary interventions.

Authors:  P W Serruys; C Di Mario; N Meneveau; P de Jaegere; S Strikwerda; P J de Feyter; H Emanuelsson
Journal:  Am J Cardiol       Date:  1993-05-20       Impact factor: 2.778

9.  Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography.

Authors:  B De Bruyne; T Baudhuin; J A Melin; N H Pijls; S U Sys; A Bol; W J Paulus; G R Heyndrickx; W Wijns
Journal:  Circulation       Date:  1994-03       Impact factor: 29.690

Review 10.  Positron emission tomography for quantitation of myocardial perfusion.

Authors:  Ornella E Rimoldi; Paolo G Camici
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952
View more
  2 in total

1.  Clinical effectiveness of coronary computed tomographic angiography in the triage of patients to cardiac catheterization and revascularization after inconclusive stress testing: results of a 2-year prospective trial.

Authors:  Aiden Abidov; Michael J Gallagher; Kavitha M Chinnaiyan; Laxmi S Mehta; James H Wegner; Gilbert L Raff
Journal:  J Nucl Cardiol       Date:  2009-07-22       Impact factor: 5.952

Review 2.  Korean guidelines for the appropriate use of cardiac CT.

Authors:  Young Jin Kim; Hwan Seok Yong; Sung Mok Kim; Jeong A Kim; Dong Hyun Yang; Yoo Jin Hong
Journal:  Korean J Radiol       Date:  2015-02-27       Impact factor: 3.500
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.